Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps
Trends in Cancer · 2025-10 · 11 (10) · 993-1004
DOI: 10.1016/j.trecan.2025.08.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-10. Verfasst von Blanca Navarro Rodrigo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL),…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Neoplasms, Immunotherapy, Adoptive. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tumor-infiltrating lymphocyte (TIL) therapy has emerged as a transformative approach in cancer immunotherapy, particularly following the recent US Food and Drug Administration (FDA) approval of lifileucel for advanced melanoma. This review synthesizes current insights into the immune correlates and mechanisms underlying the efficacy of TIL therapy, highlighting the pivotal role of tumor immunogenicity, TIL functional states, and the tumor microenvironment (TME). Recent advances in single-cell profiling and biomarker discovery have enabled more precise patient selection and therapy optimization, while novel expansion protocols and engineered TILs are addressing resistance and broadening applicability to non-melanoma tumors. Collectively, these developments underscore the promise of next-generation TIL therapies to revolutionize treatment paradigms across a wider spectrum of solid cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland; Center for Cell…
Zitieren
APA
Navarro Rodrigo, B., Ortiz Miranda, Y., Corria-Osorio, J., Coukos, G., & Harari, A. (2025). Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps. Trends in Cancer, 11(10), 993-1004. https://doi.org/10.1016/j.trecan.2025.08.002
Vancouver
Navarro Rodrigo B, Ortiz Miranda Y, Corria-Osorio J, Coukos G, Harari A. Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps. Trends in Cancer. 2025;11(10):993-1004. doi:10.1016/j.trecan.2025.08.002
BibTeX
@article{NavarroRodrigo2025,
author = {Navarro Rodrigo, Blanca and Ortiz Miranda, Yaquelin and Corria-Osorio, Jesús and Coukos, George and Harari, Alexandre},
title = {Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps},
journal = {Trends in Cancer},
year = {2025},
volume = {11},
number = {10},
pages = {993--1004},
doi = {10.1016/j.trecan.2025.08.002}
}
EUVIMED